Altimmune, Inc.
ALT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,014 | -$22,146 | -$19,575 | -$23,180 |
| Dep. & Amort. | $27 | $30 | $29 | $33 |
| Deferred Tax | $0 | $0 | -$681 | $0 |
| Stock-Based Comp. | $3,554 | $0 | $4,015 | $3,354 |
| Change in WC | $3,533 | -$472 | $73 | $2,464 |
| Other Non-Cash | $3 | $2,940 | -$701 | -$936 |
| Operating Cash Flow | -$11,897 | -$19,648 | -$16,840 | -$18,265 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$10 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$149,321 | -$4,432 | -$43,141 | -$13,213 |
| Inv. Sales/Matur. | $0 | $105,549 | $38,040 | $26,845 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$149,321 | $101,107 | -$5,101 | $13,632 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $14,596 | $0 | $0 |
| Stock Issued | $39,638 | $37,952 | $34,748 | $9,694 |
| Stock Repurch. | $0 | $0 | $170 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$289 | -$6 | -$799 | $391 |
| Financing Cash Flow | $39,349 | $52,542 | $34,119 | $10,085 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$121,869 | $134,001 | $12,178 | $5,452 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $183,147 | $49,146 | $36,968 | $31,516 |
| End Cash | $61,278 | $183,147 | $49,146 | $36,968 |
| Free Cash Flow | -$11,897 | -$19,658 | -$16,840 | -$18,265 |